Page last updated: 2024-08-24

3-iodobenzylguanidine and Hepatocellular Carcinoma

3-iodobenzylguanidine has been researched along with Hepatocellular Carcinoma in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (11.11)	18.7374
1990's	1 (11.11)	18.2507
2000's	3 (33.33)	29.6817
2010's	4 (44.44)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guan, XQ; Liu, FQ; Su, Y; Wang, YL	1
Cai, H; Huang, R; Ou, X; Wu, X; Zhao, Y; Zhong, X	1
Deng, HF; Huang, R; Jia, ZY; Ou, XH; Qi, ZZ; Yang, XC; Yang, YY	1
Bardiès, M; Buvat, I	1
Akahane, M; Ijichi, H; Inoue, Y; Kitazawa, T; Obi, S; Ohtomo, K; Omata, M; Yoshikawa, K	1
Buscombe, JR	1
Altmann, A; Haberkorn, U; Kissel, M; Kübler, W; Mahmut, M; Peschke, P; Zitzmann, S	1
Gritters, LS; Wahl, RL	1
Endo, K; Fujita, T; Inoue, G; Koizumi, M; Konishi, J; Maki, A; Mori, K; Nakano, Y; Ohta, H; Ozawa, K	1

Reviews

2 review(s) available for 3-iodobenzylguanidine and Hepatocellular Carcinoma

Article	Year
Dosimetry in nuclear medicine therapy: what are the specifics in image quantification for dosimetry? The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:1 Topics: 3-Iodobenzylguanidine; Bone Marrow; Carcinoma, Hepatocellular; Humans; Iodine Radioisotopes; Liver Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Neuroendocrine Tumors; Nuclear Medicine; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy; Radiotherapy Planning, Computer-Assisted; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2011
Single photon emission computed tomography in cancer imaging. Oncology (Williston Park, N.Y.), 1993, Volume: 7, Issue:7 Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Carcinoma, Hepatocellular; Gallium Radioisotopes; Hemangioma; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Lymphoma; Neoplasms; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon	1993

Article

Year

Dosimetry in nuclear medicine therapy: what are the specifics in image quantification for dosimetry?

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:1

Topics: 3-Iodobenzylguanidine; Bone Marrow; Carcinoma, Hepatocellular; Humans; Iodine Radioisotopes; Liver Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Neuroendocrine Tumors; Nuclear Medicine; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy; Radiotherapy Planning, Computer-Assisted; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2011

Single photon emission computed tomography in cancer imaging.

Oncology (Williston Park, N.Y.), 1993, Volume: 7, Issue:7

Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Carcinoma, Hepatocellular; Gallium Radioisotopes; Hemangioma; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Lymphoma; Neoplasms; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon

1993

Other Studies

7 other study(ies) available for 3-iodobenzylguanidine and Hepatocellular Carcinoma

Article	Year
The effects of MIBG on the invasive properties of HepG2 hepatocellular carcinoma cells. International journal of molecular medicine, 2014, Volume: 34, Issue:3 Topics: 3-Iodobenzylguanidine; ADP Ribose Transferases; Antigens, CD; Carcinoma, Hepatocellular; Cell Movement; Female; Fluorescent Antibody Technique; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Hep G2 Cells; Humans; Inhibitory Concentration 50; Integrin alpha Chains; Liver Neoplasms; Male; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Urokinase-Type Plasminogen Activator	2014
Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells. Frontiers of medicine, 2017, Volume: 11, Issue:1 Topics: 3-Iodobenzylguanidine; Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Genetic Therapy; Hep G2 Cells; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Norepinephrine Plasma Membrane Transport Proteins; Radionuclide Imaging; Radiopharmaceuticals; Transfection; Vesicular Monoamine Transport Proteins	2017
In vitro and in vivo studies of adenovirus-mediated human norepinephrine transporter gene transduction to hepatocellular carcinoma. Cancer gene therapy, 2011, Volume: 18, Issue:3 Topics: 3-Iodobenzylguanidine; Adenoviridae; Adrenal Gland Neoplasms; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Transfer Techniques; Genetic Vectors; HEK293 Cells; Hep G2 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Norepinephrine Plasma Membrane Transport Proteins; Radiography; Radionuclide Imaging; Xenograft Model Antitumor Assays	2011
False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma. The British journal of radiology, 2002, Volume: 75, Issue:894 Topics: 3-Iodobenzylguanidine; Aged; Carcinoma, Hepatocellular; Diagnosis, Differential; False Positive Reactions; Humans; Hypertension; Liver Neoplasms; Male; Neuroendocrine Tumors; Radionuclide Imaging; Radiopharmaceuticals	2002
Interventional nuclear medicine in hepatocellular carcinoma and other tumours. Nuclear medicine communications, 2002, Volume: 23, Issue:9 Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Carriers; Humans; Infusions, Intra-Arterial; Iodine Radioisotopes; Iodized Oil; Liver Neoplasms; Microspheres; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Treatment Outcome; Yttrium Radioisotopes	2002
Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:6 Topics: 3-Iodobenzylguanidine; Animals; Carcinoma, Hepatocellular; Cloning, Molecular; Humans; Liver Neoplasms, Experimental; Male; Metabolic Clearance Rate; Neoplasm Transplantation; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Organ Specificity; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Rats; Recombinant Proteins; Reference Values; Symporters; Tissue Distribution; Transduction, Genetic; Tumor Cells, Cultured	2003
Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1988, Volume: 29, Issue:6 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Carcinoma; Carcinoma, Hepatocellular; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Multiple Endocrine Neoplasia; Neoplasms, Multiple Primary; Organometallic Compounds; Pheochromocytoma; Radionuclide Imaging; Succimer; Sulfhydryl Compounds; Technetium; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms	1988